A subsequent study examining the clinical outcomes of MI patients with LV dysfunction, separated into cohorts depending on their -463G/A promoter polymorphism [179], found no relationship between the polymorphism and MPO plasma levels, but the GG genotype was associated with a significant decrease in survival over 1050 days [179]. Here, MPO is linked to myocardial infarction.